While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

Coverage of GLP-1s is not necessarily in-your-face obvious. It leads to the conversation of whether we want to pursue weight ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

Social support can improve the odds of successful weight loss. AnnaLee Canario and Dacia Benjamin say their friendship is the ...

Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

Even as Singapore attempts to revive its stock market, and despite challenging exits, private equity continues to flourish ...

QIPT Home Medical could offer up to 84% upside with activist hedge fund involvement, potential turnaround, or sale. Read more ...

With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...

Whether it’s Ozempic, Pilates, or sheer will, celebrity transformations take all shapes and sizes - so what's the hassle all ...